Core Insights - Milestone Scientific Inc. has launched the CompuFlo® Advisor Program aimed at enhancing commercial adoption and generating clinical data for Medicare reimbursement optimization [1][2] Group 1: Program Launch and Objectives - The CompuFlo® Advisor Program commenced on February 1, 2026, targeting high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor jurisdictions [2] - The program aims to generate 1,000–2,000 case submissions in the first six months to transition CPT® code 0777T from Category III to Category I status, potentially increasing commercial adoption and revenue visibility [2] Group 2: Commercial Infrastructure and Support - Milestone has established a robust commercial infrastructure to support national expansion and has engaged industry veterans for real-time claims support and payer advocacy [3] - The company is implementing a comprehensive support system, including veteran consultants and a dedicated provider hotline, to assist physicians throughout the reimbursement process [4] Group 3: Strategic Importance - The Advisor Program is considered a key strategic initiative for Milestone Scientific, moving beyond device placement to building a comprehensive commercial ecosystem [4] - The company believes that establishing reimbursement with the initial cohort will create a recurring revenue model that can be rapidly expanded to hundreds of physicians nationwide [4]